BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28746978)

  • 1. Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: a validation study on biopsies and surgical specimens.
    Koopman T; de Bock GH; Buikema HJ; Smits MM; Louwen M; Hage M; Imholz ALT; van der Vegt B
    Histopathology; 2018 Jan; 72(2):191-200. PubMed ID: 28746978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Histopathology; 2019 May; 74(6):917-924. PubMed ID: 30585668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic diagnostics of HER2 positivity in gastroesophageal adenocarcinoma.
    Koopman T; Louwen M; Hage M; Smits MM; Imholz AL
    Am J Clin Pathol; 2015 Feb; 143(2):257-64. PubMed ID: 25596252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
    Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
    Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between digital image analysis and visual assessment of immunohistochemical HER2 expression in breast cancer.
    Jakobsen MR; Teerapakpinyo C; Shuangshoti S; Keelawat S
    Pathol Res Pract; 2018 Dec; 214(12):2087-2092. PubMed ID: 30377025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program.
    Kumarasinghe MP; Morey A; Bilous M; Farshid G; Francis G; Lampe G; McCue G; Von Neumann-Cosel V; Fox SB
    Pathology; 2017 Oct; 49(6):575-581. PubMed ID: 28823752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 Heterogeneity in Gastroesophageal Cancer Detected by Testing Biopsy and Resection Specimens.
    Fazlollahi L; Remotti HE; Iuga A; Yang HM; Lagana SM; Sepulveda AR
    Arch Pathol Lab Med; 2018 Apr; 142(4):516-522. PubMed ID: 28782986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas.
    Nielsen SL; Nielsen S; Vyberg M
    Appl Immunohistochem Mol Morphol; 2017; 25(5):320-328. PubMed ID: 27801737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.
    Sun H; Kang EY; Chen H; Sweeney KJ; Suchko M; Wu Y; Wen J; Krishnamurthy S; Albarracin CT; Ding QQ; Foo WC; Sahin AA
    Breast Cancer Res Treat; 2024 Jun; 205(2):403-411. PubMed ID: 38441847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).
    Boers JE; Meeuwissen H; Methorst N
    Histopathology; 2011 Feb; 58(3):383-94. PubMed ID: 21323962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.
    Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ
    BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinoma.
    van Hagen P; Biermann K; Boers JE; Stoss O; Sleddens HF; van Lanschot JJ; Dinjens WN; Rueschoff J; Wijnhoven BP
    Dis Esophagus; 2015; 28(4):380-5. PubMed ID: 24611982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.
    Yan B; Yau EX; Choo SN; Ong CW; Yong KJ; Pang B; Salto-Tellez M
    J Clin Pathol; 2011 Oct; 64(10):880-3. PubMed ID: 21757431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
    Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
    World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical validation of human epidermal growth factor receptor 2 immunohistochemistry by the use of the A0485 antibody versus the 4B5 antibody and breast versus gastric scoring guidelines in ovarian clear cell carcinoma.
    Lin SY; Wang YH; Hsu CY; Chen YJ; Lai CR; Hang JF
    Histopathology; 2021 Nov; 79(5):758-767. PubMed ID: 34036622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.
    Huang SC; Ng KF; Lee SE; Chen KH; Yeh TS; Chen TC
    Gastric Cancer; 2016 Jan; 19(1):176-82. PubMed ID: 25512144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.
    Wang T; Hsieh ET; Henry P; Hanna W; Streutker CJ; Grin A
    Hum Pathol; 2014 May; 45(5):970-5. PubMed ID: 24656529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.
    Koopman T; van der Vegt B; Dijkstra M; Bart J; Duiker E; Wisman GBA; de Bock GH; Hollema H
    Histopathology; 2018 Nov; 73(5):852-863. PubMed ID: 29989198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.
    Fox SB; Kumarasinghe MP; Armes JE; Bilous M; Cummings MC; Farshid G; Fitzpatrick N; Francis GD; McCloud PI; Raymond W; Morey A
    Am J Surg Pathol; 2012 Apr; 36(4):577-82. PubMed ID: 22314190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.
    Tuominen VJ; Tolonen TT; Isola J
    Histopathology; 2012 Apr; 60(5):758-67. PubMed ID: 22296215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.